Cargando…

Histological tumor response predicts clinical outcome in patients with colorectal peritoneal metastasis treated with preoperative chemotherapy followed by cytoreduction and HIPEC

OBJECTIVES: Up to one quarter of the patients with colorectal cancer (CRC) develop peritoneal carcinomatosis (PM). The aims of this retrospective study were to characterize the histological response of the PM of CRC to preoperative chemotherapy and evaluate the potential prognostic value, in terms o...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Sousa, Isa Valéria Ferreira, Lopes, Joanne M.D., Nogueiro, Jorge P.M., Costa, Teresa R., Barbosa, Laura E.R., Aral, Marisa M.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067549/ https://www.ncbi.nlm.nih.gov/pubmed/37020471 http://dx.doi.org/10.1515/pp-2022-0117

Ejemplares similares

Late Recurrence of Pancreatic Solid Pseudopapillary Neoplasm With Peritoneal Carcinomatosis Treated With Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Case Report
por: Nogueiro, Jorge, et al.
Publicado: (2022)

Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
por: Spiliotis, J. D., et al.
Publicado: (2014)

Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease
por: Khan, Hamza, et al.
Publicado: (2022)

Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
por: Cardi, Maurizio, et al.
Publicado: (2015)

Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis
por: Fernández-Candela, Alba, et al.
Publicado: (2021)

Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis
por: Yurttas, Can, et al.
Publicado: (2022)

Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review
por: Yap, Daniel Ren Yi, et al.
Publicado: (2021)

Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
por: Sluiter, Nina R., et al.
Publicado: (2018)

Management of Inguinal Involvement of Peritoneal Surface Malignancies by Cytoreduction and HIPEC with Inguinal Perfusion
por: Shachar, Yair, et al.
Publicado: (2015)

Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?
por: Swain, David R., et al.
Publicado: (2018)

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
por: Simkens, Geert A, et al.
Publicado: (2017)

Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases
por: Simkens, Geert A., et al.
Publicado: (2018)

Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Jayakrishnan, Thejus T, et al.
Publicado: (2014)

Postoperative Peritonitis Without An Underlying Digestive Fistula After Complete Cytoreductive Surgery Plus HIPEC
por: Honoré, Charles, et al.
Publicado: (2013)

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
por: Vassos, Nikolaos, et al.
Publicado: (2016)

Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC
por: Simkens, Geert A, et al.
Publicado: (2021)

Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
por: Khan, Sohini, et al.
Publicado: (2022)

Cytoreductive Surgery (CRS) and Hyperthermic IntraPeritoneal Chemotherapy (HIPEC): don’t throw the baby out with the bathwater
por: Königsrainer, Alfred, et al.
Publicado: (2018)

Practice patterns, attitudes, and knowledge among physicians regarding cytoreductive surgery and HIPEC for patients with peritoneal metastases
por: Bernaiche, Tyler, et al.
Publicado: (2018)

Peritoneal metastases of rare carcinomas treated with cytoreductive surgery and HIPEC – A single center case series
por: Brandl, Andreas, et al.
Publicado: (2017)

Cytoreductive surgery and HIPEC in a 14 years old patient with peritoneal recurrence of adenocarcinoma of the right colon
por: Sorrentino, Lorena, et al.
Publicado: (2019)

Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies
por: Harper, Megan M., et al.
Publicado: (2022)

ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC
por: Khan, Sohini, et al.
Publicado: (2022)

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in small bowel adenocarcinoma with peritoneal metastasis: a systematic review
por: Chen, Vicky, et al.
Publicado: (2022)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes
por: Rosa, Fausto, et al.
Publicado: (2021)

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)
por: Rovers, Koen P., et al.
Publicado: (2019)

ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases
por: Sluiter, Nina R., et al.
Publicado: (2018)

Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
por: Larsen, S. G., et al.
Publicado: (2021)

Beware of lethal Wernicke's encephalopathy after cytoreductive surgery with HIPEC for peritoneal pseudomyxoma: Case report of morbidity and mortality review
por: Lahnaoui, Oumayma, et al.
Publicado: (2022)

Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
por: Marrelli, Daniele, et al.
Publicado: (2022)

Impact of extent of parietal peritonectomy on oncological outcome after cytoreductive surgery and HIPEC
por: Somashekhar, S.P., et al.
Publicado: (2019)

Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations
por: Pelz, Joerg OW, et al.
Publicado: (2006)

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol
por: Kuijpers, Anke M. J., et al.
Publicado: (2013)

Reply to “Letter to the Editor on Yurttas C et al. Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis”
por: Yurttas, Can, et al.
Publicado: (2023)

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study
por: van der Kaaij, Rosa T, et al.
Publicado: (2017)

Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case
por: Sugarbaker, Paul H.
Publicado: (2021)

Case series on high grade appendiceal cancer with peritoneal and liver carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Roy, Susmit Prosun, et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on the availability and implementation of cytoreductive surgery and HIPEC in patients with peritoneal carcinomatosis at the Wroclaw Comprehensive Cancer Center
por: Szewczyk, Krzysztof, et al.
Publicado: (2023)

Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence
por: Pasqual, Enrico Maria, et al.
Publicado: (2023)

The use of Hypotension Prediction Index in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Gangakhedkar, Gauri R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_07sovjgs9tn11gal3aocpjdcnj